Costs and effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland - an Analysis of the EUROPA Study Including 1251 Polish Patients.

W. Ken Redekop, Ewa Orlewska, Pawel Maciejewski, Frans F. H. Rutten, Louis W. Niessen

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)861-877
Number of pages17
JournalPharmacoEconomics
Volume26
Issue number10
DOIs
Publication statusPublished - 2008

Cite this